All stock lists
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
29.42+0.66 (+2.29%)
Insider Score
––Not scored
KMTS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
KMTS analyst forecast
KMTS analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
KMTS 12-month price target
$34.00+15.6% upsideaverage of 1 firm
$34.00High
$34.00Low
Best analysts covering KMTS
- Wells Fargo100%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
KMTS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Evercore ISI | — | $34.00 | +15.8% | — | 2026-10-20 | |
| — | BTIG | Buy | — | — | Reiterated | 2026-09-15 |
| — | BTIG | Buy | — | — | Reiterated | 2026-09-02 |
| — | BTIG | Buy | — | — | Reiterated | 2026-07-15 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-04-09 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-07 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-25 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-18 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-12-15 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-12-12 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-12-12 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-07-17 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2025-04-16 |
KMTS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-17 | -0.60 | -0.61 | $22.9M | $24.6M |
| 2026-07-14 | -0.59 | -0.67 | $26.5M | $28.6M |
| 2026-09-14 | -0.62 | -0.75 | $29.0M | $31.0M |
| 2026-12-10 | -0.61 | 0.00 | $32.1M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.